Spectrum Pharmaceuticals | SPPI - Ordinary Share Capital


Spectrum Pharmaceuticals reported $205K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.



Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Actinium Pharmaceuticals USD 31.2M 0 Sep/2025
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
Amgen USD 539M 1000K Dec/2025
Arrowhead Research USD 135.7M 2.44M Sep/2025
Astellas Pharma JPY 1.79B 195K Dec/2025
AstraZeneca USD 1.55B 206K Dec/2025
Bayer EUR 982.42M 0 Dec/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Coherus Biosciences USD 121.16M 4.92M Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Incyte USD 198.46M 2.33M Dec/2025
J&J USD 2.41B 584K Sep/2025
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Novartis USD 1.91B 10.64M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Puma Biotechnology USD 5K 0 Jun/2024
Roche Holding CHF 795.62M 699.54K Dec/2025
Takeda JPY 1.58B 2K Dec/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025